Rare diseases
Investigational molecules
Locations
Study on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol
GermanyStudy of Inhaled Pirfenidone for Patients with Progressive Pulmonary Fibrosis
GermanyStudy on the Safety and Effectiveness of Elafibranor for Adults with Primary Sclerosing Cholangitis
GermanyStudy of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies
GermanyStudy on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
GermanyStudy on the Safety and Effectiveness of Azetukalner for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications
GermanyStudy of Belantamab Mafodotin for Patients with Relapsed or Refractory AL Amyloidosis
GermanyStudy of AMG 193 alone and combined with docetaxel for treatment of advanced MTAP-null solid tumors in adult patients
GermanyStudy on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)
GermanyStudy on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer
GermanyStudy Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement
GermanyStudy on Tafasitamab with Gemcitabine, Oxaliplatin, and Rituximab for Patients with Aggressive B-cell Lymphoma
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
